Open science will be one of the priorities of the Dutch presidency of the European Union in 2016.

Academics are challenging the control of a select group of publishing houses over scientific journals.

US judges dismiss injunctions against journals.

An increasing number of universities fuse. This is shown by a recent report of the European University Association. [in GERMAN]

[8]Editas, a company started by several gene-editing pioneers, gets new funding to develop treatments for blood cancers, eye diseases, and sickle-cell anemia.

[5]Frontiers dismisses 31 of its editors, based on escalated opposition to the publisher’s unique publication model.

The European Commission has abandoned consideration of 'Science 2.0', finding it too ambitious.

Open access journal SoftwareX publishes cross-discipline, peer-reviewed software that has been developed during the research process.

A Russian computer scientist was fired from his job at a university in the Netherlands last year after Dutch intelligence officers warned he was spying for his home country.

Times Higher Education analysis reveals the institutions with the most Nobel prizewinners this century.

[3]Opinion piece that calls for bioethics to ‘get out of the way’ prompts self-reflection among ethicists.

The new Scopus Article Metrics module includes new metrics based on four alternative metrics categories.

Google's biotech Calico will delve into the genetic database amassed by a unit of Ancestry.com to look for hereditary influences on longevity.

More than 1,000 artificial intelligence researchers have signed an open letter issued that calls for a ban on autonomous weapons that select and engage targets without human intervention.

Research Councils UK has published its response to the independent Review of the implementation of the RCUK policy on Open Access, chaired by Professor Sir Bob Burgess.

Senate panel approved a bill that would require U.S. science agencies to make the peer-reviewed research papers they fund freely available to the public.

The US is committed to building a computer some 30x more powerful than today's top machine.

Federal spending on research and development has fallen by 7% largely due to a freeze in research collaborations with the EU following the February 2014 vote to limit EU immigration.

Cindy Wu, a recent college graduate, had a great idea — and when she explained it, investors opened up their checkbooks

Massive study seeks to succeed where others failed, but faces tight deadline and questions about strategy.

Dalmeet Singh Chawla rounds up the recent discussion about single figure publications.

Survey results released last week by the American Society for Cell Biology (ASCB) included an interesting nugget. Some 72% of respondents said that they had been unable to replicate a published experimental result. Yet a higher proportion (77%) said that they had never been told that their work could not be replicated.

Another domino has fallen in a chain of retractions for Robert Weinberg, the man who discovered the first tumor-causing gene in humans.

Women in university leadership are paid up to 11.4% less than men in equivalent jobs, according to a [10]new study.

Critics of the present system of science funding say it's rather like modern football where the richest clubs are the most successful, which makes them even richer enabling them to continue to be successful.

Dynasty Foundation liquidated after Ministry of Justice labels it a 'foreign agent'.

A provision in a new biomedical innovation bill passed last week in the House of Representatives would create a new program to launch prize competitions at the NIH.

Miguel Seabra has stepped down as president of research-advocacy group Science Europe with immediate effect. Elisabeth Monard, secretary-general of the Research Foundation Flanders, will be acting president until it elects a new president at its general assembly in November.

The country's economic crisis is hitting researchers hard.

The Netherlands are negotiating with publishers about an OA policy. They managed to achieve agreements with some publishers, but not with Elsevier.